Today: 21 May 2026
Browse Category

NYSE:NOC 2 June 2025 - 29 June 2025

SpaceX Wins $81.6 Million U.S. Space Force Deal to Launch WSF-M2 Weather Satellite in 2027

Space News Roundup – June 29, 2025

Japan’s H-2A rocket flew its 50th and final mission June 28, launching the GOSAT-GW satellite. Blue Origin’s New Shepard carried six tourists June 29, with Carl Kuehner becoming the 750th person in space. SpaceX launched two Falcon 9 rockets within 13 hours, deploying Starlink satellites and extending its streak to over 200 consecutive successes. Rocket Lab completed two Electron launches in under 48 hours from New Zealand.
Today in Space / June 28, 2025 0:00

Today in Space / June 28, 2025 0:00

SpaceX’s Starship exploded during a static-fire test in Texas, while its Axiom-4 mission docked with the ISS, sending India’s Shubhanshu Shukla to the station for the first time. NASA’s Artemis booster test ended in a nozzle explosion. JWST directly imaged exoplanet TWA 7b and mapped over 800,000 galaxies. Asteroid 2024 YR4 has a 4% chance of striking the Moon in December 2032.
28 June 2025
Operation Midnight Hammer: How Stealth Bombers, Fighters, and Bunker Busters Obliterated Iran’s Nuclear Sites

Operation Midnight Hammer: How Stealth Bombers, Fighters, and Bunker Busters Obliterated Iran’s Nuclear Sites

Seven B-2 bombers from Whiteman AFB struck Iran’s Fordow, Natanz, and Isfahan nuclear sites on June 21–22, 2025, using 14 GBU-57A/B Massive Ordnance Penetrators in the weapon’s first combat use. Tomahawk missiles from an Ohio-class submarine hit Isfahan. F-22s, F-35s, and electronic warfare aircraft suppressed Iranian defenses. Satellite imagery confirmed major damage at Fordow.
Satellite Bus Showdown: Legacy Titans vs. NewSpace Mavericks (2024–2033)

Satellite Bus Showdown: Legacy Titans vs. NewSpace Mavericks (2024–2033)

The global satellite bus market is projected to grow from $14.1 billion in 2023 to $23.4 billion by 2033. SpaceX has launched over 6,500 Starlink satellites, making up about half of all active satellites. In 2024, commercial projects accounted for 68% of market value, with LEO satellites at 72% of platform share. BAE Systems completed its $5.55 billion acquisition of Ball Aerospace in early 2024.
Inside America’s Silent Sentinels: The Untold Story of GSSAP in Space Surveillance

Inside America’s Silent Sentinels: The Untold Story of GSSAP in Space Surveillance

GSSAP-1 and GSSAP-2 launched July 28, 2014, from Cape Canaveral, with GSSAP-3 and GSSAP-4 following in 2016 and GSSAP-5 and GSSAP-6 in 2022, expanding the U.S. surveillance constellation in geosynchronous orbit. The satellites have drawn international scrutiny for close approaches to Russian and Chinese GEO satellites. GSSAP-2 was retired to graveyard orbit in August 2023. GSSAP-7 and 8 are planned for launch by 2027.
5 June 2025
Military Satellite Services: Complete Guide to Secure Communications

Military Satellite Services: Complete Guide to Secure Communications

The U.S. operates AEHF for secure military communications, Navstar GPS for global navigation, DSP and SBIRS for missile warning, and KH-11 satellites for reconnaissance. Russia fields the Liana ELINT constellation, while China’s BeiDou navigation system offers global PNT and military messaging. China’s 2007 and Russia’s 2021 ASAT tests produced major debris clouds. The U.S. Space Development Agency plans 160 new satellites by 2025.
Global Drone Market Outlook (2025–2030)

Global Drone Market Outlook (2025–2030)

The global drone market reached $73 billion in 2024, with forecasts ranging from $163 billion to $260.5 billion by 2030. DJI holds 70–80% of the consumer drone market, while military drones are projected to grow from $36–37 billion in 2024 to up to $90 billion by 2030. Delivery drones could exceed $10 billion by 2030. Asia-Pacific leads growth, with China supplying over 70% of civilian drones.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop